Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults.

Galcanezumab for migraine prevention had higher direct costs over 24 months but superior adherence and longer treatment duration compared with standard care.

Advice was presented for clinicians regarding the benefits and harms of cannabis or cannabinoids for the management of chronic noncancer pain.

The FDA has accepted for review the sBLA for fremanezumab-vfrm for the prevention of episodic migraine in pediatric patients aged 6 to-17 years weighing at least 45 kg.

Some recent cuts at US government health agencies may be reversed, including a key program that tracks lead exposure in children.

We explore the current guidance for osteoporosis screening in men, as well as barriers to access for both clinicians and ...

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

A group of 23 states and Washington, DC, is suing the US Department of Health and Human Services over a sudden cut of $12 billion in public health funding.

The inability to pay for health care has reached its highest point in the United States, according to the results of a survey released April 2 by the West Healt ...

Degenerative disc disease is common among young adults with PsA, with key risk factors including older age, male sex, diabetes, and inflammatory back pain.

Weeks after ordering staff back to the office, the US Food and Drug Administration is now letting some employees work from home again.

[O]ur study indicates that inadequate pain control, leading to prolonged pain duration, puts patients at a higher risk of sensory impairments, particularly in vision, smell, and taste functions.